Mint Trails Crème Brûlée in JUUL Relaunch Odds Despite Leading Historical Sales

---

JUUL's Best-Selling Flavor Ever Just Fell Behind Crème Brûlée in the Relaunch Market

In 2019, JUUL voluntarily pulled mint pods from the U.S. market at a time when mint outsold every other JUUL flavor combined. It was the company's flagship product for adult switchers, and its removal was a concession to political pressure over youth vaping rates, not a reflection of weak demand. Today, prediction markets are pricing mint's return at just 37% in the "What flavors will JUUL relaunch in 2026?" contract, a 17-percentage-point collapse over three days from its recent 54% level.

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

Mint

Consensus YES price across 1 venues

15%average

KalshiBest YES price16¢

Mango

Consensus YES price across 1 venues

6%average

KalshiBest YES price9¢

Cucumber

Consensus YES price across 1 venues

1%average

KalshiBest YES price9¢

Mint

Consensus YES price across 1 venues

52%average

PolymarketBest YES price98¢

That puts Mint below Crème Brûlée, which trades at 56% on Polymarket. The dessert flavor never came close to mint's commercial dominance during JUUL's peak years. Mango sits at 24%, Cucumber at 27%, and Fruit Medley at 24%. The only flavor the market considers more likely to relaunch than mint is one that barely registered in JUUL's original sales mix. No confirmed news event in the past 72 hours explains the repricing. The move may reflect position liquidation or a shift in trader sentiment about regulatory timelines, but the absence of a clear catalyst makes the magnitude worth scrutinizing.

---

The FDA Just Cleared a Non-Tobacco Pod for the First Time, So Why Is Mint Falling?

The regulatory backdrop should, in theory, be favorable. In May 2026, the FDA authorized marketing of the first non-tobacco, non-menthol ENDS pods ever cleared through the premarket tobacco product application pathway: mango and blueberry variants for competitor brand Glas. That decision broke a years-long pattern in which the agency approved only tobacco and menthol flavors. JUUL itself received marketing orders in July 2025 for Virginia Tobacco and Menthol JUULpods at both 3% and 5% nicotine concentrations.

The company has also been active on the regulatory front. In May 2026, JUUL submitted comments in response to the FDA's draft guidance on flavored e-cigarette applications, emphasizing adult switching data and age-gating protocols. That filing signals intent to pursue flavored product authorizations. If the FDA's door is opening, mint would seem to be the most defensible flavor JUUL could bring forward: it has the strongest adult-use data, the highest historical sales volume, and a clear analog in the combustible tobacco market through menthol cigarettes. Yet the market moved against it anyway.

---

What the Mint Market Is Actually Pricing in the JUUL Relaunch Race

The most plausible explanation for the disconnect is that traders are pricing JUUL's corporate risk calculus, not just regulatory probability. Mint sits at the center of the political narrative that nearly destroyed the company. When research emerged in 2019 showing that mint was the most popular flavor among teenage JUUL users, it became the single most cited data point in congressional hearings and state attorney general lawsuits. JUUL's decision to pull mint was not a product recall ordered by the FDA; it was a strategic retreat to preserve the company's ability to operate at all.

That history creates a specific problem. Even if the FDA's framework now permits mint pod applications, JUUL's leadership may calculate that relaunching mint before December 31, 2026 reopens reputational and legal exposure. The company settled multistate litigation for $462 million in 2023 and remains subject to consent agreements that restrict its marketing practices. Launching a niche flavor like Crème Brûlée, which never carried the same youth-appeal stigma, could be a lower-risk way to test the FDA's flavored-product pathway without drawing the political attention mint inevitably attracts.

There is also a technical explanation worth noting: Kalshi and Polymarket prices for Mint diverge sharply, with Kalshi showing 14% and Polymarket showing 60%. That spread suggests thin liquidity on at least one platform and makes the composite 37% figure unreliable as a consensus signal. Traders looking at individual venues would reach very different conclusions about mint's prospects.

---

The Case for Mint: Why This Price Could Be Wrong

The strongest bull case for Mint rests on three concrete facts. First, JUUL's own regulatory filings lean heavily on adult switching data, and mint generated more of that data than any other flavor in the company's history. A PMTA submission for mint would carry the richest evidence base of any flavored JUUL product. Second, the FDA's July 2025 authorization of JUUL's menthol pods establishes that the agency considers cooling and mint-adjacent flavor profiles acceptable when supported by population-level benefit data. Mint is one step removed from menthol, not a fruit or dessert novelty. Third, the Glas authorization in May 2026 proves the FDA is now willing to clear non-tobacco flavors, removing the categorical barrier that previously blocked all flavored applications.

If JUUL has already submitted or is preparing a PMTA for mint, the current 37% price implies the market expects either an FDA rejection or a timeline that extends past December 31, 2026. Both are plausible, but neither is certain. FDA review timelines have historically stretched beyond 12 months, and the resolution deadline is roughly five months away. The market may be correctly pricing the calendar risk even if it underestimates the regulatory probability. For traders, the question is whether JUUL has already filed. No public information confirms a mint PMTA submission, and without that, December 31 is a hard wall.

Mint at 37% is not irrational. It is a bet that the most politically toxic flavor in vaping history stays on the shelf for five more months, even as regulators open the door. The market may be right about the timing and wrong about the trajectory. Anyone buying mint here is betting that JUUL moves faster than its institutional caution would suggest.